Prader-Willi Syndrome (PWS) Global Clinical Trials Review, H1, 2018
- GDHC5018CTIDB
- Pages: 59
- May 2018
- Total Views:1127
- Region : Global
- GlobalData
- Market Research Report
Details
Prader-Willi Syndrome (PWS) Global Clinical Trials Review, H1, 2018
Summary
GlobalData's clinical trial report, Prader-Willi Syndrome (PWS) Global Clinical Trials Review, H1, 2018" provides an overview of Prader-Willi Syndrome (PWS) clinical trials scenario. This report provides top line data relating to the clinical trials on Prader-Willi Syndrome (PWS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table Of Content
Scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials 23
Prominent Drugs 24
Latest Clinical Trials News on Prader-Willi Syndrome (PWS) 25
May 29, 2018: Saniona reports positive results from Phase 1 study with new Tesomet tablet 25
May 14, 2018: Soleno Therapeutics Announces Initiation of Phase III Clinical Trial of DCCR in Prader-Willi Syndrome 25
Apr 27, 2018: INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) for Treatment of Prader-Willi Syndrome 25
Apr 26, 2018: Saniona progress to second part of Phase 2a study for Tesomet in Prader-Willi Syndrome based on positive results in adult patients 26
Clinical Trial Profile Snapshots 27
Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Source 59
List Of Figure
List of Figures
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Region (%), 2018* 6
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 9
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 10
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 11
Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials, G7 Countries (%), 2018* 12
Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 13
Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 14
Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials, E7 Countries (%), 2018* 15
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 16
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 17
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 18
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 19
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 20
Prader-Willi Syndrome (PWS) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 21
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 22
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 23
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 24
GlobalData Methodology 58
List Of Table
List of Tables
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Region, 2018* 6
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 9
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 10
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, North America, Top Countries, 2018* 11
Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials, G7 Countries (%), 2018* 12
Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 13
Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 14
Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials, E7 Countries (%), 2018* 15
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Phase, 2018* 16
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 17
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 18
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 19
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 20
Prader-Willi Syndrome (PWS) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 21
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 22
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 23
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 24
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Prader-Willi Syndrome (PWS) Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Prader-Willi Syndrome (PWS), Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania
Companies
Novo A/S
Zafgen Inc
Soleno Therapeutics Inc
Chong Kun Dang Pharmaceutical Corp
Pfizer Inc
Novartis AG
Insys Therapeutics Inc
Ferring Holding SA
Eli Lilly and Co
Corporacion Parc Tauli
Company Profile
Company Profile Title
Prader-Willi Syndrome (PWS) Global Clinical Trials Review, H1, 2018
Summary
GlobalData's clinical trial report, Prader-Willi Syndrome (PWS) Global Clinical Trials Review, H1, 2018" provides an overview of Prader-Willi Syndrome (PWS) clinical trials scenario. This report provides top line data relating to the clinical trials on Prader-Willi Syndrome (PWS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials 23
Prominent Drugs 24
Latest Clinical Trials News on Prader-Willi Syndrome (PWS) 25
May 29, 2018: Saniona reports positive results from Phase 1 study with new Tesomet tablet 25
May 14, 2018: Soleno Therapeutics Announces Initiation of Phase III Clinical Trial of DCCR in Prader-Willi Syndrome 25
Apr 27, 2018: INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) for Treatment of Prader-Willi Syndrome 25
Apr 26, 2018: Saniona progress to second part of Phase 2a study for Tesomet in Prader-Willi Syndrome based on positive results in adult patients 26
Clinical Trial Profile Snapshots 27
Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Source 59
List Of Figure
List of Figures
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Region (%), 2018* 6
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 9
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 10
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 11
Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials, G7 Countries (%), 2018* 12
Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 13
Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 14
Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials, E7 Countries (%), 2018* 15
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 16
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 17
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 18
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 19
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 20
Prader-Willi Syndrome (PWS) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 21
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 22
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 23
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 24
GlobalData Methodology 58
List Of Table
List of Tables
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Region, 2018* 6
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 9
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 10
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, North America, Top Countries, 2018* 11
Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials, G7 Countries (%), 2018* 12
Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 13
Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 14
Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials, E7 Countries (%), 2018* 15
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Phase, 2018* 16
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 17
Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 18
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 19
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 20
Prader-Willi Syndrome (PWS) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 21
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 22
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 23
Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 24
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Prader-Willi Syndrome (PWS) Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Prader-Willi Syndrome (PWS), Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania
Companies
Novo A/S
Zafgen Inc
Soleno Therapeutics Inc
Chong Kun Dang Pharmaceutical Corp
Pfizer Inc
Novartis AG
Insys Therapeutics Inc
Ferring Holding SA
Eli Lilly and Co
Corporacion Parc Tauli
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 130 | 
December 2020
Page 130 | December 2020
Page 131 | November 2020
Page 95 | November 2020
Page 96 | August 2020